[Activities of rifabutine and rifampicin against Mycobacterium avium complex infections in mice and in peritoneal macrophages].
Saito
H
H
Sato
K
K
Tomioka
H
H
D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D008168:Lung / Q000382:microbiology; D008264:Macrophages / Q000187:drug effects*; D051379:Mice; D008815:Mice, Inbred Strains; D009162:Mycobacterium avium / Q000187:drug effects; D010587:Phagocytosis / Q000187:drug effects; D017828:Rifabutin; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use*; D012294:Rifamycins / Q000494:pharmacology / Q000627:therapeutic use*; D013154:Spleen / Q000382:microbiology; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D012294:Rifamycins; D017828:Rifabutin; D012293:Rifampin